Researchers are edging closer to something long imagined but never quite within reach: a single vaccine platform that could ...

In the hubbub and widespread criticism that accompanied the CDC’s new recommended childhood vaccine schedule, released this ...

Twenty years on since the approval of the first human papillomavirus (HPV) vaccine, a raft of studies involving millions of people have reached the same conclusion: HPV vaccination is safe and ...

HPV vaccination offers herd immunity, and one dose is just as effective as two, as new CDC guidance reflects. The post HPV ...

Aston Sci. Inc., a clinical-stage biopharmaceutical company pioneering next-generation therapeutic cancer vaccines, announced ...

Lung cancer is hard to catch early and even harder to survive once it is found. A new clinical trial will test whether a ...

Development of a DNA-based lung cancer vaccine in the United Kingdom received funding for 2 years of laboratory research and initial manufacture of 3000 doses, according to a press release from the ...

The study examined 180 patients with advanced lung cancer who received a COVID vaccine within 100 days before or after beginning immunotherapy, as well as 704 similar patients who did not. Vaccinated ...

Subcutaneous immunotherapy injections work the same way as their intravenous counterparts — by changing or enhancing a person’s immune responses to cancer. Immunotherapy for cancer is a broad category ...

Neoantigens are unique markers that distinguish only cancer cells. By adding B cell reactivity, cancer vaccines can move ...

Last August, Labroots covered the decision of the National Health Service of England (NHS England) to allow subcutaneous (under the skin) injections of programmed death ligand 1 (PD-L1) blocker called ...

Becomes available free of charge for nine-year-old girls at EPI centres; other provinces expected to follow suit.